Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
Elliot B TapperDevin AberasturiZhe ZhaoChia-Yang HsuNeehar D ParikhPublished in: Alimentary pharmacology & therapeutics (2020)
Hepatic encephalopathy remains morbid and associated with poor outcomes among contemporary patients. Gastroenterology consultation and combination lactulose-rifaximin are both associated with improved outcomes. These data inform the development of care coordination efforts for subjects with cirrhosis.